Portal Instruments, Inc.
Portal Instruments is developing a needle-free drug delivery platform for effortless delivery and a transformed patient experience. Portal’s platform is in development and not available for sale or use. Portal Instruments is focused on needle-free drug delivery and solving the challenge of self-administering biological medicines. Portal’s platform is in development and not available for sale or use. We are developing a highly innovative needle-free jet injection platform licensed from MIT, that transforms the drug delivery experience for patients suffering from chronic disease. Our aim is to replace all needles and syringes with a safe, fast, and connected device and to become the standard for modern drug delivery.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
Our Fundamentals
At Portal we believe that patients deserve more than a 160 year old technology, the needle & syringe
Our Vision is a Needle Free World
Our Mission is to improve the experience for patients on life-changing therapies
Our Values
- We are patient-centric and everything we do focuses around improving the patient experience and outcome
- We partner with pharma companies to improve and enable their life-changing therapies and are the easiest, smartest company to partner with
- We bring to market innovative, creative, and disruptive ideas in the field of drug delivery
- We hold ourselves to the highest standards of honesty, integrity, and intellectual rigor
- We realize that it will take an amazing and diverse team to fulfill our mission and value teamwork, collegiality, transparency and inclusion
- We can only expand our organization by continuously teaching and growing our people
- We are relentless about finding clear solutions to real problems efficiently
- We are results-driven and will do what it takes to get it done
Our Plan
To build a needle-free drug delivery system that is transformative, interactive, and easy to use, and to go to market with pharmaceutical partners who develop life-changing biologics and biosimilars that treat chronic diseases.